Search research articles
Contact Us
Filters
Showing results (111-120 of 157) with videos related to
Page
of 16
Sort By:
Journal of Internal Medicine
|
September 29, 2001
Fatal adverse drug events: the paradox of drug treatment
I Buajordet, J Ebbesen, J Erikssen, et al.
Journal of Internal Medicine
|
September 1, 1994
Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients
M Hurlen, J Erikssen, P Smith, et al.
Journal of Internal Medicine
|
November 1, 1993
Haematocrit: a predictor of cardiovascular mortality?
G Erikssen, E Thaulow, L Sandvik, et al.
Clinical Genetics
|
August 1, 1997
Analyses of mutations in the human renal kallikrein (hKLK1) gene and their possible relevance to blood pressure regulation and risk of myocardial infarction
K E Berge, A Bakken, M Bøhn, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 30, 1990
[Testing of a computer program model for the diagnosis of suspected acute coronary disease]
J Jonsbu, O Aase, K E Arnesen, et al.
Clinical Genetics
|
December 1, 1993
Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction
M Bøhn, K E Berge, A Bakken, et al.
Clinical Radiology
|
October 19, 2004
Inter-observer agreement in audit of quality of radiology requests and reports
K Stavem, T Foss, O Botnmark, et al.
Heart (British Cardiac Society)
|
May 18, 2004
Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study
J Bodegard, G Erikssen, J V Bjornholt, et al.
Scandinavian Cardiovascular Journal : SCJ
|
February 24, 2001
Hypothesis: the recent decline in coronary heart disease mortality--mainly a shift from fatal to non-fatal events?
G Erikssen, K Liestøl, J V Bjørnholt, et al.
British Journal of Clinical Pharmacology
|
January 1, 1982
Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol)
J Erikssen, E Thaulow, R Mundal, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 157) with videos related to
Sort By:
Page
of 16
Journal of Internal Medicine
|
September 29, 2001
Fatal adverse drug events: the paradox of drug treatment
I Buajordet, J Ebbesen, J Erikssen, et al.
Journal of Internal Medicine
|
September 1, 1994
Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients
M Hurlen, J Erikssen, P Smith, et al.
Journal of Internal Medicine
|
November 1, 1993
Haematocrit: a predictor of cardiovascular mortality?
G Erikssen, E Thaulow, L Sandvik, et al.
Clinical Genetics
|
August 1, 1997
Analyses of mutations in the human renal kallikrein (hKLK1) gene and their possible relevance to blood pressure regulation and risk of myocardial infarction
K E Berge, A Bakken, M Bøhn, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 30, 1990
[Testing of a computer program model for the diagnosis of suspected acute coronary disease]
J Jonsbu, O Aase, K E Arnesen, et al.
Clinical Genetics
|
December 1, 1993
Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction
M Bøhn, K E Berge, A Bakken, et al.
Clinical Radiology
|
October 19, 2004
Inter-observer agreement in audit of quality of radiology requests and reports
K Stavem, T Foss, O Botnmark, et al.
Heart (British Cardiac Society)
|
May 18, 2004
Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study
J Bodegard, G Erikssen, J V Bjornholt, et al.
Scandinavian Cardiovascular Journal : SCJ
|
February 24, 2001
Hypothesis: the recent decline in coronary heart disease mortality--mainly a shift from fatal to non-fatal events?
G Erikssen, K Liestøl, J V Bjørnholt, et al.
British Journal of Clinical Pharmacology
|
January 1, 1982
Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol)
J Erikssen, E Thaulow, R Mundal, et al.
Page
of 16